search
for
 About Bioline  All Journals  Testimonials  Membership  News


Iranian Journal of Pediatrics
Tehran University of Medical Sciences Press
ISSN: 1018-4406 EISSN: 2008-2150
Vol. 18, Num. 4, 2008, pp. 369-372








Iranian Journal of Pediatrics, Vol. 18, No. 4, Dec, 2008, pp. 369-372

Association of Distal Renal Tubular Acidosis with Hypercalcemia; Report on Three Cases

Piman Eshraghi*1, MD, Pediatric Endocrinologist; Hamdollah Karamifar2, MD, Pediatric Endocrinologist; Ali Derakhshan2, MD, Pediatric Nephrologist

  1. Pediatric Research Center, Babol University of Medical Sciences, Babol, IR Iran
  2. Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, IR Iran

* Correspondence author; Address: Research Center Amirkola Children Hospital Babol University of Medical SciencesBabol-Iran. E-mail: p.eshraghi@bprc.ir

Received: 05/02/08; Revised: 21/04/08; Accepted: 10/07/08

Code Number: pe08059

Abstract

Background:Hypercalcemia is an endocrine emergency that should be diagnosed as soon as possible and managed carefully. For better management multiple causes of hypercalcemia must be taken into consideration.
Case presentation:We observed three infants with hypercalcemia and distal renal tubular acidosis at the time of diagnosis during 5 years. The patients were referred with severe dehydration and failure to thrive.
Conclusion:There was no reason for hypercalcemia found in these patients except distal renal tubular acidosis. So we suggest distal renal tubular acidosis as a cause for hypercalcemia.

Key Words: Hypercalcemia; Distal renal tubular acidosis; RTA; Failure to thrive

Introduction

Hypercalcemia may be caused by hyperparathyroidism, hyperthyroidism, vitamin D intoxication, malignancy, low phosphate diet, sedentary life style, and William's syndrome[1].

Renal tubular acidosis (RTA) is a kind of hyperchloremic anion gap acidosis. Its pathogenesis is accepted to be a defect in urine acidification. Types of RTA include:

Type І: distal RTA

Type ІІ: proximal RTA

Type ІV: mineralocorticoid deficiency

Distal RTA was described in 1949 as a clinical syndrome with hypokalemia. hyperchloremic metabolic acidosis and inability to decrease urinary pH to <5.5, nephrocalcinosis, nephrolithiasis, osteo-malacia and rickets[4]. As the distal part of nephron maintains the pH gradient between urine and blood, the failure to do this, is called distal RTA (dRTA)[5]. In dRTA, there is no evidence of hypercalcemia[1-5].  

In 2002, Maruyama reported a 28-day-old newborn with dRTA and hypercalcemia and suggested that distal RTA could occur with hypercalcemia only in neonatal period[6]. Pela  in 2003 introduced two 5-month-old infants with distal RTA and hypercalcemia, so the association of hypercalcemia and distal RTA in other ages became obvious[7].

In this study we introduce three cases with distal RTA associated with hypercalcemia without any other etiology being found for hypercalcemia.

Case presentation

First patient: A3-month-old female infant was admitted with recurrent vomiting in 2001. Birth weight 3250 gr. Dehydration, depressed fontanel, dried mucosa and irritability was noted. Laboratory data is reviewed in table 1.

In sonography, there was diffused severe, bilateral Medullary nephrocalcinosis. After rehydration with normal saline, potassium, chloride and sodium bicarbonate for three days, recovery occurs. Treatment continues with administration of polycitrate. At beginning 5 meq/kg/day bicarbonate was needed and now she needs 2 meq/kg/day. In the meantime the patient is 5 years old and weighs 18.5 kg.

Table 1- Clinical and laboratory findings in patients

 

First patient

Second patient

Third patient

Age (months)

3

4.5

2

Major clinical manifestation

FTT, recurrent vomiting, dehydration

Recurrent vomiting, lethargy, dehydration, constipation

Poor feeding, lethargy, weight loss

Calcium (mg/dl)

15

12.7

15.6

Phosphate (mg/dl)

5

3.4

6

Bun (mg/dl)

40

14

66

Creatinin (mg/dl)

1.1

0.8

0.6

Sodium (meq/l)

131

135

138

Potassium (meq/l)

2.9

2.2

2.9

Chloride (meq/l)

113

115

119

Total Serum Protein (gr/dl)

5.7

5.5

5.9

Serum pH

7.22

7.29

7.26

Serum Bicarbonate (meq/l)

14.7

10.8

6

Anion gap  [Na-(Cl+HCO3)](meq/l)

7

10

13

Parathyroid hormone

25 (OH) Vit D3

Nl*

Nl

Nl

Cortisol

Nl

Nl

Nl

Thyroid function test

Nl

Nl

Nl

24 hr urine Ca (mg)

17

(>5 mg/kg/day)

81.9

(10 mg/kg/day)

15

(>4 mg/kg/day)

Maternal Ca (mg/dl)

9.6

10.2

9.6

Urine specific gravity (gr/ml)

1.004

1.005

1.004

Urine acidity (pH)

7.8

7

7

         * Normal

Second patient: A 4.5-month-old female infant whose parents are first degree relatives of the first patient (Mothers are sisters and fathers are brothers). She was admitted in 2001 with recurrent vomiting, lethargy and dehydration. Patient had been well until 20 days before admission and then recurrent vomiting, irritability, confusion and dehydration occurred. Constipation was mentioned during that 20 days. Her weight on admission was 5300 gr (<5%).

Laboratory findings are reviewed in table 1. Sonography showed bilateral Medullary calcification. After treatment with normal saline and sodium bicarbonate for two days, without diuretic or corticosteroid therapy, hypercalcemia and acidosis could be corrected. Now she is 5 years old and weighs 18 kg (50%). Under treatment with 2 meq/kg/day bicarbonate as Shohl's and polycitrate solutions she remains without hypercalcemia.

Third patient: A 2-month-old female infant was admitted in 2002 with poor feeding, lethargy and weight loss after birth. She weighed 3500 gr at birth with good Apgar scores. At admission she was severely dehydrated and weighed 3200 gr (5%). Sonologist reported bilateral Medullaryy nephrocalcinosis. After supportive care and furosemide adminstration (1 mg/kg/day) for 3 days, recovery occurred. The patient is now normocalcemic under treatment with polycitrate solution in outpatient clinic.

Discussion

Symptoms of hypercalcemia include muscle weakness, anorexia, nausea, vomiting, constipation, polyuria, polydipsia, weight loss and fever. In addition, prolonged hypercalcemia causes nephrocalcinosis and progressive deterioration of renal function[2]. These findings commonly were present in our patients.

Insufficiency of urine acidification and need for bicarbonate therapy for 5 years in the first and second patient and occurrence of nephrocalcinosis are the reasons for diagnosis of dRTA. Also laboratory data and bilateral Medullaryy nephrocalcinosis in the third patient are typical for dRTA. The common point in these three patients is the presence of dRTA and transient hypercalcemia without recurrence in early infancy. Also in other studies, the oldest patient was 5 months old[6,7,8].

In a letter published in Pediatric Nephrology, Rodriguez-soriano et al commented that dRTA is a possible etiology of hypercalcemia in newborns[9]. In Maruyama study, hypercalcemia and dRTA was present in a  28-day-old  newborn  with  weight  loss and dehydration. Hypercalcemia was corrected after 7 days of fluid and alkali therapy. Seven months later the treatment was discontinued to rule out transient types of dRTA, hypercalcemia with dRTA recurred and this confirmed the association between hypercalcemia and dRTA.

In Pela study two 5-month-old infants are introduced. In both of them hypercalcemia and acidosis was corrected after 2 days of therapy. This study proved that hyper-calcemia and dRTA may occur after neonatal period. 

Association of hypercalcemia and distal RTA may be caused by:

  1. Severe decrease in extracellular volume at the time of hospital admission (raised BUN). This causes decreased glumerolar filtration rate and consequently increased calcium reabsoption in proximal tubules as seen in thiazide therapy.
  2. Acidosis causes bone breakdown and release of calcium from bone. The decreased glumerolar filtration rate and defect in calcium excreation, leads to hypercalcemia.
  3. Renal immaturity in early infancy may predispose to hypercalcemia which is not seen is older children.

Conclusion

This study introduces three patients with distal RTA and hypercalcemia. The cause of hypercalcemia could be assumed idiopathic. Distal RTA causes transient hypercalcemia, but under certain circumstances, hyper-calcemia can be suggested as a cause of dRTA.

References

  1. Doyle DA, Digeorge AM. Hyperpara­thyroidism. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 18th ed. Philadelphia; Saunders. 2007; Pp:2340-8.
  2. Monk RD, Bushinsky DA. Kidney stones. In: Larsen PR, Kronenberg HM, Melmed Sh, et al (eds). Williams Textbook of Endocrinology. 11th ed. Philadelphia; Saunders. 2008; Pp:1224-41.
  3. Miller DL, Doppman JL. Diagnostic imaging of the adrenal glands. In: Becker KL (ed). Principles and Practice of Endocrinology and Metabolism. Philadelphia; Lippincott, Williams & Wilkins. 2001; Pp:684-5.
  4. Sabatini SA. Renal tubular acidosis. In: Massry ShG, Glassock RJ (eds). Textbook of Nephrology. Philadelphia; Lippincott, Williams & Wilkins. 2001; Pp:411-20.
  5. Herrin JT. Renal tubular acidosis. In: Avner E, Harmon W, Niaudet P (eds). Pediatric Nephrology. Philadelphia; Lippincott, Wiliams & Wilkins. 2004; Pp:757-75.
  6. Maruyama KE, Shinohara MA. Distal renal tubular acidosis associated with hypercalcemia and nephrocalcinosis in an infant. Pediatr Nephrol. 2002;17(1): 977-8.
  7. Pela IV, Seracini DA. Hypercalcemia and distal renal tubular acidosis: an association not only in the newborn. Pediatr Nephrol. 2003;18(2):850.
  8. Rodriguez SJ, Vallo A, Castilo G, Oliveros R. Natural history of primary distal renal tubular acidosis treated since infancy. J Pediatr. 1982;101(1):669-76.
  9. Rodriguez SJ, Garcia FM, Vallo A, et al. Hypercalcemia in neonatal distal renal tubular acidosis. Pediatr Nephrol. 2000; 14(1):354-5.

© Copyright 2008 - TUMS PUBLICATIONS


The following images related to this document are available:

Photo images

[pe08059t1.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil